Concepedia

Neill A. Giese

NA

Statistics

Publications

33

Citations

5.5K

H-Index

26

Active since

1981

Affiliations

Millennium Engineering and Integration (United States)(Current)

Kyowa Kirin (Japan)

The Ohio State University

Howard Hughes Medical Institute

Dana-Farber Cancer Institute

Neill A. Giese is an author at Millennium Engineering and Integration (United States) specializing in medicine, cell biology, and drug discovery.

Top concepts

Publications per year

1981–2011

33

Publications

33

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman et al. · Blood · 2010 · 712 citations · Full text

Co-localization of NG2 proteoglycan and PDGF ?-receptor on O2A progenitor cells in the developing rat brain

Akiko Nishiyama, Xiaohong Lin, Neill A. Giese et al. · Journal of Neuroscience Research · 1996 · 626 citations

The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

Julia Hoellenriegel, Sarah Meadows, Mariela Sivina et al. · Blood · 2011 · 547 citations · Full text

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E.M. Herman, Amber Gordon, Amy J. Wagner et al. · Blood · 2010 · 541 citations · Full text

Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.

Nathalie A. Lokker, Carol M. Sullivan, Stanley J. Hollenbach et al. · PubMed · 2002 · 436 citations

, , +16

1–5 of 33